Buy Ajanta Pharma, target Rs 1,300: Kunal Bothra
ETMarkets.com|
Oct 31, 2017, 12.09 PM IST
Independent analyst Kunal Bothra has a buy call on Ajanta Pharma with a target price of Rs 1,300.
The current market price of Ajanta Pharma is Rs 1,253.10.
Time period given by the analyst is intraday when Ajanta Pharma price can reach defined target.
Kunal Bothra recommended to keep a stop loss at Rs 1,220.
Ajanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 10,853.95 Crore) operating in Pharmaceuticals and health care sector.
The company's top management includes Dr.Anil Kumar, Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar Dalal, Mr.Purushottam B Agrawal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal.
Company has Kapoor & Parekh Associates as its auditors.
As on 30-09-2017, the company has a total of 88,014,500 shares outstanding.
The current market price of Ajanta Pharma is Rs 1,253.10.
Time period given by the analyst is intraday when Ajanta Pharma price can reach defined target.
Kunal Bothra recommended to keep a stop loss at Rs 1,220.
Ajanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 10,853.95 Crore) operating in Pharmaceuticals and health care sector.
The company's top management includes Dr.Anil Kumar, Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar Dalal, Mr.Purushottam B Agrawal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal.
Company has Kapoor & Parekh Associates as its auditors.
As on 30-09-2017, the company has a total of 88,014,500 shares outstanding.
